With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm... Show more
Kimberly-Clark shares have traded in a relatively narrow band through late August 2026, finishing near $109.55 after a decline of about 3% over the trailing 30 days. The move reflects a choppy but resilient consumer-staples backdrop rather than a single dominant catalyst, with the stock holding up better than its 18.5% decline over the past year amid broader market strength. Investors continue to weigh near-term demand softness in China and North America against the company's durable productivity engine, a forward price-to-earnings multiple near 14.7x that sits below the consumer-staples peer average, and an attractive dividend yield. The shares remain a defensive, income-oriented holding as management works through discrete operational headwinds while advancing two transformative transactions.
Kimberly-Clark is a global manufacturer of essential personal care and hygiene products, operating through three segments: Personal Care, Consumer Tissue, and K-C Professional. Its portfolio includes well-known brands such as Huggies, Pull-Ups, Kleenex, Scott, Cottonelle, Kotex, Poise, and Depend, sold in more than 175 countries. The company's competitive strengths include iconic brand equity, broad distribution across retail and professional channels, and scale in manufacturing and procurement. Under its "Powering Care" strategy, Kimberly-Clark emphasizes science-backed innovation, revenue growth management, and productivity initiatives to defend market share in mature markets while expanding in higher-growth enterprise markets. The company's essential categories tend to generate relatively stable, resilient demand, which supports its reputation as a dependable dividend payer.
Kimberly-Clark reported second-quarter 2026 results on August 4, posting net sales of $4.19 billion, which missed consensus, and adjusted earnings per share of $2.12, which exceeded expectations. Organic sales declined 0.1%, held back by a social-media-driven diaper disruption in China and trade inventory reductions in North America, including the impact of a Los Angeles distribution-center fire. Management lowered its 2026 outlook, now expecting organic sales growth about 100 basis points below weighted-average category growth of roughly 2%.
Offsetting the sales pressure, the company delivered record gross productivity of 6.4%, a $45 million tariff refund, and a 190-basis-point expansion in adjusted gross margin. It also completed the launch of Arbex, its tissue and hygiene joint venture with Suzano, and reported strong progress on integration planning for its acquisition of Kenvue (KVUE), which is tracking toward a fourth-quarter 2026 close with a $1.9 billion cost-synergy target. The company additionally unveiled a proprietary alternative natural-fiber program. Analyst activity was mixed-to-constructive: Piper Sandler reiterated an Overweight rating with a $121 price target, while Freedom Broker upgraded the stock to Buy.
Tickeron's Trending AI Robots page highlights a curated selection of automated trading strategies from a broader universe of hundreds of AI-driven bots that monitor thousands of tickers. Only the top-performing and most relevant bots appear in this section, giving traders a focused view of strategies currently gaining traction in the market. These bots vary in approach, timeframe, and performance metrics, from short-term momentum systems to longer-horizon models, so investors can compare them based on their own objectives and risk tolerance. For those seeking data-driven ways to track stocks like KMB, exploring the Trending AI Robots section offers a practical starting point for evaluating automated trading tools.
Looking ahead, Kimberly-Clark's trajectory hinges on several factors. The pace of recovery in its China diaper business is a key swing factor, with management estimating a roughly 200-basis-point sales headwind and about $70 million of operating profit pressure in the second half. The company also expects around $150 million of gross input-cost headwinds tied to higher oil-linked costs, which it plans to offset through pricing and productivity. Investors should monitor category growth in North America, which slowed sequentially, as well as the timing and execution of the Kenvue acquisition and the realization of its cost synergies. The new alternative natural-fiber platform represents a longer-term innovation opportunity. Broader risks include commodity inflation, competitive promotion, and any disruption to the pending transaction.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Stochastic Oscillator for KMB moved into oversold territory on September 01, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KMB advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on September 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KMB as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for KMB turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
KMB moved below its 50-day moving average on August 31, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for KMB crossed bearishly below the 50-day moving average on September 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KMB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for KMB entered a downward trend on August 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (20.367) is normal, around the industry mean (18.443). P/E Ratio (21.162) is within average values for comparable stocks, (43.428). Projected Growth (PEG Ratio) (2.155) is also within normal values, averaging (2.757). Dividend Yield (0.047) settles around the average of (0.034) among similar stocks. P/S Ratio (2.151) is also within normal values, averaging (1.985).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KMB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company, which engages in the manufacturing of paper based products and providing cleaning solutions
Industry HouseholdPersonalCare